| 9 April 2013
A warning letter sent to an Italian subsidiary of Pfizer, Wyeth Lederle S.p.A., by the US Food and Drug Administration (FDA) claims that the company's Catania, Italy manufacturing facility has Read More...
| 5 February 2013
The Italian national regulatory agency, AIFA, has called upon pharmaceutical companies to include gender-disaggregated data in the submission of regulatory documents, including marketing approval Read More...
| 5 June 2012
It’s an ongoing challenge for companies to get products and manufacturing facilities approved by regulatory authorities—and that’s before natural disasters strike, potentially leaving their research Read More...